 |
The third annual Expanded Access Summit, Expanded Access 3.0, was held January 27-29 2020 at the National Press Club, Washington DC |
Dr. Tony Fauci on the “Parallel Track” origins of Expanded Access
Dr. Tony Fauci on the “Parallel Track” origins of Expanded Access
Online Mini-Conference Series:
Expanding Access to new medicines in COVID19 and other therapeutic areas: Achieving a true “Learning Healthcare System”
Session 1: Date TBD, 12:00pm – 3:00pm EST
The Expanded Access prospect for researchers, hospitals, and clinical care providers
Session 2: Date TBD, 12:00pm – 3:00pm EST
The Value of secondary data sources in the drug development process
Session 3: Date TBD, 12:00pm – 3:00pm EST
Scorecard for pre-market access in the COVID19 response: EA, EUA, virtual trials, and master protocols
Online Mini-Conference Series:
Expanding Access to new medicines in COVID19 and other therapeutic areas: Achieving a true "Learning Healthcare System"
LOG IN TO DOWNLOAD THE EA3 PRESENTATION SLIDES
All presentation slides have been gathered into a zip folder and made available for download by registered attendees. To begin, please enter your email address and the password that was provided to you after the close of the conference.
A Few of our featured speakers
Our three-day summit brings together nationally renowned speakers from industry, medicine, and policy centers. Join us for the latest innovations in pre-market access to medicines.
Toni Fauci, MD
Director, National Institute of Allergy and Infectious Diseases (NIAID), NIH
Suanna Bruinooge, MPH
Director of Research Strategy, CENTRA, American Society of Clinical Oncology (ASCO)
Robert Walker, MD
Director, Division of Clinical Development, Biomedical Advanced Research and Development Authority (BARDA), HHS
Paul Aliu, PharmD
Global Head Medical Governance, Chief Medical Office, Novartis Pharmaceuticals
Bringing together world leaders in integrating treatment-use trials into the clinical development of new therapeutics for serious diseases.
National Press Club
Washington, D.C.
Get on the alert list for the “Industry Best Practices” publication and for Expanded Access 3.0 program updates!
Inclusivity in Clinical Drug Development
2017 FDARA (PDUFA VI) calls for better patient representation in the clinical development process through a combination research trials and expanded access trials. Join the discussion on optimizing these two channels for engaging more patients.
An Emerging Marketplace for Early Access?
Are we prepared for a marketplace for research-stage medicines? Who pays for exploratory treatment options? There is demand, a capability to supply, and regulatory systems that accommodate informed choice.
Get Past the Politics
The Summit is for unbiased, intellectual discussion on how early access works and how it can be put to better use. Our all-star panelists will cut through the recent noise that has obscured the core issues of feasibility, ethics, and value.
The Real Opportunity for Real World Data
Expanded Access may be the largest source of consented patient outcomes information, from which to inform further research studies, strengthen regulatory claims, and improve provider care decisions. Learn the history and latest approaches.
Collaborative Access Networks
Can we make Expanded Access more feasible for research centers and clinics? See the latest innovative partnerships among doctors, health systems, pharmaceutical companies, and granting organizations.
PRECISION MEDICINE AND CLINICAL DISCOVERY
Conference Location
The National Press Club
The 2020 Expanded Access Summit will take place in the Ballroom of the National Press Club, a historic venue at the heart of Washington D.C.
JW MARIOTT
OFFICIAL CONFERENCE HOTEL
Located just around the corner from our conference venue at the National Press Club, the JW Mariott is within easy walking distance of the White House, the National Mall, Ford’s Theatre and the Smithsonian Museums.
Book Online
Registered conference attendees can secure a special rate at the JW Mariott using this link.
Book by Phone
If you prefer to book by phone, please call 1-(562)-513-2218
National Press Club
JW Mariott
Join Attendees from world-class
companies and organizations
2017 companies included Pfizer, Takeda, Janssen, Bayer, Eli Lilly, Biogen, Alnylam, Vertex, Bluebird, Amicus, Ultragenyx, AmpliPhi, Wave Life Sciences, Neuralstem, Incyte, Asuragen, Astellas, Tesaro, Ovid, Spectrum, ALS Association, Parent Project Muscular Dystrophy, Kids V Cancer, BIO, FDA, NIH, Patient Advocate Foundation, the FNIH Biomakers Consortium, and more.
Past Attendees by Organization Type
- Life Science Companies 60%
- Government & Non-Profits 22%
- Service Providers 18%
Industry Attendees by Job Function
- Clinical Development and Research 35%
- Medical Affairs 31%
- Central/Executive 18%
- Regulatory Affairs 16%
OUR CURRENT PARTNERS
